DEVELOPING THE FUTURE OF CANCER THERAPEUTICS

INVITED SPEAKERS

Stephanie Dougan, Ph.D.
Combination Immunitherapies: Clues from the Microenvironment

Pasi Jänne, M.D., Ph.D.
EGFR Mutant Lung Cancer: From Clinic to Bench and Back to Clinic

Jeffrey Karp, Ph.D.
Towards Accelerated Medical Innovation

Martin Nowak, Ph.D. 
The Evolutionary Dynamics of Cancer
 

STUDENT SPEAKERS

Lara Gechijian, Bradner & Gray Labs
Targeting TRIM24 for Degradation With a Bromodomain-VHL Ligand Conjugate

Caitlin Nichols, Beroukhim Lab
Loss of Heterozygosity of Essential Genes: A Novel Class of Cancer Vulnerabilities